Authors:
WURFLEIN D
DECHANT M
STOCKMEYER B
TUTT AL
HU PS
REPP R
KALDEN JR
VANDEWINKEL JGJ
EPSTEIN AL
VALERIUS T
GLENNIE M
GRAMATZKI M
Citation: D. Wurflein et al., EVALUATING ANTIBODIES FOR THEIR CAPACITY TO INDUCE CELL-MEDIATED LYSIS OF MALIGNANT B-CELLS, Cancer research, 58(14), 1998, pp. 3051-3058
Citation: T. Valerius et al., ACTIVATED NEUTROPHILS AS EFFECTOR-CELLS FOR BISPECIFIC ANTIBODIES, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 142-145
Authors:
VALERIUS T
WURFLEIN D
ELSASSER D
STOCKMEYER B
REPP R
WEINER G
GLENNIE M
KALDEN JR
VANDEWINKEL JGJ
GRAMATZKI M
Citation: T. Valerius et al., EVALUATING B-CELL PANEL ANTIBODIES IN ADCC WITH G-CSF NEUTROPHILS AS EFFECTOR-CELLS, Tissue antigens, 48(4-II), 1996, pp. 111-111
Authors:
VALERIUS T
REPP R
ELSASSER D
WURFLEIN D
WEINER GJ
DEO Y
KALDEN JR
VANDEWINKEL JJG
GLENNIE MJ
GRAMATZKI M
Citation: T. Valerius et al., HLA CLASS-II AS POTENTIAL TARGET ANTIGEN ON MALIGNANT B-CELLS FOR THERAPY WITH BISPECIFIC ANTIBODIES IN COMBINATION WITH G-CSF, Blood, 86(10), 1995, pp. 2132-2132